New Generic Drugs in 2011-2012


Generic drugs can save you money. What are considered generic drugs? According to the FDA:
"A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price."
Below are two lists* for drugs which are soon to become "generic" for the years 2011 and 2012.

2011

Brand Name----Generic Name----Availibility

Uroxatral------------------------- alfuzosin------------------------July
Zyprexa---------------------------olanzapine----------------------October
Lipitor-----------------------------atorvastatin--------------------November
Caduet----------------------------amlodipine----------------------November
Tazorac----------------------------tazarotene cream---------------November

2012

Brand Name----Generic Name----Availibility
Lexapro---------------------------escitalopram--------------------February
Entocort EC-----------------------budesonide----------------------February
Avandia---------------------------rosiglitazone--------------------March
Avandaryl-------------------------glimepiride---------------------March
Avandamet-----------------------metformin-----------------------March
Boniva----------------------------ibandronate---------------------March
Seroquel--------------------------quetiapine-----------------------March
Avapro----------------------------irbesartan----------------------March
Avalide---------------------------hydrochlorothiazide-------------March
Provigil---------------------------modafinil------------------------April
Plavix-----------------------------clopidogrel----------------------May
Viramune-------------------------nevirapine-----------------------May
Lescol-----------------------------fluvastatin----------------------June
Tricor-----------------------------fenofibrate----------------------July
Clarinex--------------------------desloratadine--------------------July
Singulair--------------------------montelukast---------------------August
Actos-----------------------------pioglitazone----------------------August
Exforge---------------------------amlodipine-valsartan------------September
Diovan----------------------------valsartan------------------------September
Diovan HCT----------------------hydrochlorothiazide--------------September
Geodon---------------------------ziprasidone----------------------September
Combivir-------------------------lamivudine-zidovudine-----------November
Atacand--------------------------candesartan---------------------December
Maxalt---------------------------rizatriptan-----------------------December

*these lists are provided by Excellus BlueCross BlueShield, a nonprofit Independent Licensee of the BlueCross BlueShield Association.

Facts and Myths about Generic Drugs

Fact: 7 in 10 prescriptions in the United States are filled by generic drugs.

Myth: Brand name drugs are safer than generic drugs. Fact: FDA receives very few reports of adverse events about specific generic drugs. Most reports of adverse events are related to side effects of the drug ingredient itself.

To learn more facts and myths concerning generic drugs, please visit the FDA site.

Comments